Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk
|Effective start/end date||1/1/15 → 5/31/17|
- THE UNIVERSITY OF ALABAMA AT BIRMINGHAM
- NATIONAL INSTITUTES OF HEALTH (NIH)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.